These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32538242)

  • 21. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research.
    Zhang A; Sun H; Yan G; Wang P; Wang X
    Biomed Chromatogr; 2016 Jan; 30(1):7-12. PubMed ID: 25739660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological disorders.
    Hankey GJ; Berkovic SF
    Med J Aust; 2000 Apr; 172(8):393. PubMed ID: 10840493
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolomics for laboratory diagnostics.
    Bujak R; Struck-Lewicka W; Markuszewski MJ; Kaliszan R
    J Pharm Biomed Anal; 2015 Sep; 113():108-20. PubMed ID: 25577715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
    Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
    Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preface.
    DeKosky ST; Asthana S
    Handb Clin Neurol; 2019; 167():ix. PubMed ID: 31753160
    [No Abstract]   [Full Text] [Related]  

  • 26. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics and the diagnosis of human diseases--a guide to the markers and pathophysiological pathways affected.
    Medina S; Dominguez-Perles R; Gil JI; Ferreres F; Gil-Izquierdo A
    Curr Med Chem; 2014 Mar; 21(7):823-48. PubMed ID: 24251573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics analysis for biomarker discovery: advances and challenges.
    Monteiro MS; Carvalho M; Bastos ML; Guedes de Pinho P
    Curr Med Chem; 2013; 20(2):257-71. PubMed ID: 23210853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent and potential developments of biofluid analyses in metabolomics.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    J Proteomics; 2012 Feb; 75(4):1079-88. PubMed ID: 22079244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in lipidomics: Analytical and clinical perspectives.
    Sethi S; Brietzke E
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics as a promising tool for early osteoarthritis diagnosis.
    de Sousa EB; Dos Santos GC; Duarte MEL; Moura V; Aguiar DP
    Braz J Med Biol Res; 2017 Sep; 50(11):e6485. PubMed ID: 28953990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of validated biomarkers obtained through metabolomics.
    López-López Á; López-Gonzálvez Á; Barker-Tejeda TC; Barbas C
    Expert Rev Mol Diagn; 2018 Jun; 18(6):557-575. PubMed ID: 29808702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics studies in brain tissue: A review.
    Gonzalez-Riano C; Garcia A; Barbas C
    J Pharm Biomed Anal; 2016 Oct; 130():141-168. PubMed ID: 27451335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical metabolomics paves the way towards future healthcare strategies.
    Collino S; Martin FP; Rezzi S
    Br J Clin Pharmacol; 2013 Mar; 75(3):619-29. PubMed ID: 22348240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolomic Insight into Polycystic Ovary Syndrome-An Overview.
    Rajska A; Buszewska-Forajta M; Rachoń D; Markuszewski MJ
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32659951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging role of metabolomics in protein conformational disorders.
    Gupta N; Ramakrishnan S; Wajid S
    Expert Rev Proteomics; 2021 May; 18(5):395-410. PubMed ID: 34227444
    [No Abstract]   [Full Text] [Related]  

  • 37. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OMICS insights into cancer histology; Metabolomics and proteomics approach.
    Tayanloo-Beik A; Sarvari M; Payab M; Gilany K; Alavi-Moghadam S; Gholami M; Goodarzi P; Larijani B; Arjmand B
    Clin Biochem; 2020 Oct; 84():13-20. PubMed ID: 32589887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A look at neurology].
    Regli F
    Rev Med Suisse Romande; 1997 Aug; 117(8):607-11. PubMed ID: 9340716
    [No Abstract]   [Full Text] [Related]  

  • 40. Functional metabolomics: from biomarker discovery to metabolome reprogramming.
    Peng B; Li H; Peng XX
    Protein Cell; 2015 Sep; 6(9):628-37. PubMed ID: 26135925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.